Taimei Technology - Logo white

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

March 18th, 2024
Melbourne, Australia
Event Type:

    This BioSymposium will explore the complex AI landscape. What are the ethical and practical challenges of using this technology to diagnose conditions and make treatment recommendations? When is AI integration compulsory and who bears responsibility? And what potential sanctions are imminent for non-use?  Meet with Iñaki Berasategui, Business Development Director.

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma

March 18th, 2024

Event Type: In-Person
This BioSymposium will explore the complex AI landscape. What are the ethical and practical challenges of using this technology to diagnose conditions and make treatment recommendations? When is AI integration compulsory and who bears responsibility? And what potential sanctions are imminent for non-use?  Meet with Iñaki Berasategui, Business Development Director.

Attending

Nate Zhang

VP, Taimei Technology

GM, Clinical Research and Overseas Business

CEO, Taimei Technology US

Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma
Melbourne, Australia
Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma
March 18th, 2024

Event Type: In-Person

Attending

Nate Zhang

VP, Taimei Technology

GM, Clinical Research and Overseas Business

CEO, Taimei Technology US

Email
LinkedIn
Facebook
Twitter
Crossing the Rubicon in AI Decision-Making: A Clinical Dilemma
Melbourne, Australia
This listing has been expired.

Contact Sales

Contact Our Support